Follow this innovation
[ via 
] [?]
Use of N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections
Institute for Hepatitis and Virus Research
posted on 02/15/2009
Provided are methods and compositions for treating hepatitis virus infections in mammals, especially humans. The methods comprise (1) administering N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds alone or in combination with nucleoside antiviral agents, nucleotide antiviral agents, mixtures thereof, or immunomodulating/immunostimulating agents, or (2) administering N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds alone or in combination with nucleoside antiviral agents, nucleotide antiviral agents, or mixtures thereof, and immunomodulating/immuno-stimulating agents.
File Number: 99-1B
Disease: Infectious Diseases
| Patent Number(s): | 6809083 |
|---|
This innovation currently is not available for online licensing. Please contact Ethan Byler at Institute for Hepatitis and Virus Research for more information.
request more info
ProfileFind more innovations
